Le Lézard
Classified in: Health
Subjects: SVY, WOM, MAT, DEI

DESPITE INCREASING ACCESS, WOMEN STILL CRAVE MORE CANNABIS EDUCATION, ACCORDING TO NATIONAL SURVEY


More than 6 out of 10 women say they're cannabis curious and are more likely to consider using cannabis if it's doctor-recommended

ELLICOTT CITY, Md., Oct. 24, 2022 /PRNewswire/ -- As more states legalize cannabis, it's no surprise that 62 percent of women in the U.S. say they're cannabis curious, according to a new survey from Blissiva, makers of a line of doctor-formulated cannabis-infused products designed for women. The survey, which was conducted in October 2022 among more than 1,000 American women, reveals that while women are interested in learning about the health benefits of using cannabis, they are more open to using cannabis if it's recommended by a doctor.  

"I have high hopes that more people will learn about the endocannabinoid system," said Dr. Leslie Apgar.
Canna-Curiosity  

The upcoming midterm elections signal an increased interest in cannabis among Americans with five states ? Missouri, North Dakota, South Dakota, Arkansas and Maryland ? voting on recreational use in November. While the survey shows women are overwhelmingly canna-curious, they perhaps aren't aware of how cannabis can specifically target common health issues, such as menopausal and perimenopausal symptoms, and more education is needed.

"Around menopause women start to complain about weight gain, increased anxiety, and trouble sleeping, but what many women don't realize is cannabis can be very effective at treating these and other menopause symptoms," said Dr. Leslie Apgar, OB-GYN and cofounder of Blissiva. "Cannabis is calorie-free, can reduce anxiety and help you achieve more restful sleep, which is associated with cellular repair, immune function, growth and recovery."

Grass or A Glass? 

As an OB-GYN with more than 20 years of experience treating women, Dr. Apgar says that cannabis consumption has fewer negative side effects when compared to drinking a glass of wine or another type of alcohol.  

"Cannabis is a good alternative or balanced compliment to alcohol, as it doesn't have any calories or sugar and is very helpful at treating anxiety. It can help you relax and recover without the hangover," said Dr. Apgar.  

Prescriptive Acceptance 

As more states legalize cannabis, the social acceptance will likely increase, and the stigma will fade. Until then, the survey results show that while women are cannabis curious, they're still hesitant and need guidance when it comes to usage. 

Dr. Apgar empowers women to speak to a medical professional about alternative treatments when traditional methods aren't helping. However, she warns that not all medical professionals have extensive knowledge of cannabis. "Don't be discouraged if you need to talk to more than one doctor to get the support you need."

High Hopes

Dr. Apgar calls cannabis "a game-changer" for people who've struggled to find the right treatment for their health issues. She has found that cannabis can play a valuable role in supporting individuals with anything from minor aches and pains to serious issues like post-traumatic stress disorder (PTSD) or opioid addictions.

"I've found that every cannabis user ? regardless of any 'recreational' or 'medical' label, is using it to heal something," said Dr. Leslie Apgar. "I have high hopes that more people will learn about the endocannabinoid system, which is our most primitive nervous system, and discover how cannabis can support them on their health and wellness journeys."

For more information on Blissiva's doctor-formulated cannabis-infused products and why cannabis matters, visit www.blissiva.com.

Survey Methodology 

Blissiva/Greenhouse Wellness commissioned Atomik Research to conduct a national online survey of 1,012 women across the United States.?? 

The margin of error fell within +/- 3 percentage points with a confidence interval of 95 percent. The fieldwork for the online survey took place between October 3 and October 6 of 2022. Atomik Research is an independent, creative market research agency.?  

About Blissiva 

Blissiva, founded by Gina Dubbé and Dr. Leslie Apgar, is a women-owned company specializing in producing and distributing cannabis products specifically formulated for the female body. Blissiva's line of cannabis-infused products includes the Balance Pen, which helps women combatting anxiety find relief, and the Soothe Pen, which provides liberation from chronic pain without side effects like grogginess. The company's tagline "Gyno-Created, Goddess-Approved", is a nod to the company's founders and the medical viability of the product. For more information, visit www.blissiva.com.

SOURCE Blissiva


These press releases may also interest you

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

3 jui 2024
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: